Literature DB >> 26462614

Mutation Update of ARSA and PSAP Genes Causing Metachromatic Leukodystrophy.

Martina Cesani1, Laura Lorioli1,2, Serena Grossi3, Giulia Amico3, Francesca Fumagalli1,4, Ivana Spiga5, Mirella Filocamo3, Alessandra Biffi1.   

Abstract

Metachromatic leukodystrophy is a neurodegenerative disorder characterized by progressive demyelination. The disease is caused by variants in the ARSA gene, which codes for the lysosomal enzyme arylsulfatase A, or, more rarely, in the PSAP gene, which codes for the activator protein saposin B. In this Mutation Update, an extensive review of all the ARSA- and PSAP-causative variants published in the literature to date, accounting for a total of 200 ARSA and 10 PSAP allele types, is presented. The detailed ARSA and PSAP variant lists are freely available on the Leiden Online Variation Database (LOVD) platform at http://www.LOVD.nl/ARSA and http://www.LOVD.nl/PSAP, respectively.
© 2015 WILEY PERIODICALS, INC.

Entities:  

Keywords:  ARSA; PSAP; arylsulfatase A; metachromatic leukodystrophy; mutation; saposin B

Mesh:

Substances:

Year:  2015        PMID: 26462614     DOI: 10.1002/humu.22919

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  26 in total

Review 1.  Gene therapy for metachromatic leukodystrophy.

Authors:  Jonathan B Rosenberg; Stephen M Kaminsky; Patrick Aubourg; Ronald G Crystal; Dolan Sondhi
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

2.  Leukocyte and Dried Blood Spot Arylsulfatase A Assay by Tandem Mass Spectrometry.

Authors:  Xinying Hong; Arun Babu Kumar; Jessica Daiker; Fan Yi; Martin Sadilek; Fabiola De Mattia; Francesca Fumagalli; Valeria Calbi; Roberta Damiano; Maria Della Bona; Giancarlo la Marca; Adeline L Vanderver; Amy T Waldman; Laura Adang; Omar Sherbini; Sarah Woidill; Teryn Suhr; Joanne Kurtzberg; Maria L Beltran-Quintero; Maria Escolar; Alessandro Aiuti; Alan Finglas; Amber Olsen; Michael H Gelb
Journal:  Anal Chem       Date:  2020-04-16       Impact factor: 6.986

3.  Metachromatic leukodystrophy: Biochemical characterization of two (p.307Glu→Lys, p.318Trp→Cys) arylsulfatase A mutations.

Authors:  Adem Özkan; Hatice Asuman Özkara
Journal:  Intractable Rare Dis Res       Date:  2016-11

4.  Rare Diseases in Glycosphingolipid Metabolism.

Authors:  Hongwen Zhou; Zhoulu Wu; Yiwen Wang; Qinyi Wu; Moran Hu; Shuai Ma; Min Zhou; Yan Sun; Baowen Yu; Jingya Ye; Wanzi Jiang; Zhenzhen Fu; Yingyun Gong
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 5.  Adulthood leukodystrophies.

Authors:  Wolfgang Köhler; Julian Curiel; Adeline Vanderver
Journal:  Nat Rev Neurol       Date:  2018-01-05       Impact factor: 42.937

6.  Arylsulphatase A Pseudodeficiency (ARSA-PD), hypertension and chronic renal disease in Aboriginal Australians.

Authors:  Dave Tang; Michaela Fakiola; Genevieve Syn; Denise Anderson; Heather J Cordell; Elizabeth S H Scaman; Elizabeth Davis; Simon J Miles; Toby McLeay; Sarra E Jamieson; Timo Lassmann; Jenefer M Blackwell
Journal:  Sci Rep       Date:  2018-07-19       Impact factor: 4.379

7.  Central Precocious Puberty in a Child With Metachromatic Leukodystrophy.

Authors:  Gilda Belli; Emanuele Bartolini; Andrea Bianchi; Mario Mascalchi; Stefano Stagi
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-24       Impact factor: 5.555

8.  Allogenic hematopoietic stem cell transplantation in two siblings with adult metachromatic leukodystrophy and a systematic literature review.

Authors:  Cecilie Videbæk; Jette Stokholm; Henrik Sengeløv; Lone U Fjeldborg; Vibeke Andrée Larsen; Christian Krarup; Jørgen E Nielsen; Sabine Grønborg
Journal:  JIMD Rep       Date:  2021-05-06

9.  Identification of a novel mutation in ARSA gene in three patients of an Iranian family with metachromatic leukodystrophy disorder.

Authors:  Neda Golchin; Mohammadreza Hajjari; Reza Azizi Malamiri; Majid Aminzadeh; Javad Mohammadi-Asl
Journal:  Genet Mol Biol       Date:  2017-11-06       Impact factor: 1.771

10.  Pharmacokinetic Modeling of Intrathecally Administered Recombinant Human Arylsulfatase A (TAK-611) in Children With Metachromatic Leukodystrophy.

Authors:  Steven Troy; Margaret Wasilewski; Jack Beusmans; C J Godfrey
Journal:  Clin Pharmacol Ther       Date:  2020-02-25       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.